389 related articles for article (PubMed ID: 15146031)
21. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
[TBL] [Abstract][Full Text] [Related]
22. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
Ceglia I; Acconcia S; Fracasso C; Colovic M; Caccia S; Invernizzi RW
Br J Pharmacol; 2004 Jun; 142(3):469-78. PubMed ID: 15148253
[TBL] [Abstract][Full Text] [Related]
23. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
[TBL] [Abstract][Full Text] [Related]
24. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
25. Hippocampus 5-HT(1A)-receptors attenuate cocaine-induced hyperlocomotion and the increase in hippocampal but not nucleus accumbens 5-HT.
Müller CP; Thönnessen H; Barros M; Tomaz C; Carey RJ; Huston JP
Hippocampus; 2004; 14(6):710-21. PubMed ID: 15318330
[TBL] [Abstract][Full Text] [Related]
26. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
27. Memory time-course: mRNA 5-HT1A and 5-HT7 receptors.
Perez-Garcia G; Meneses A
Behav Brain Res; 2009 Aug; 202(1):102-13. PubMed ID: 19447286
[TBL] [Abstract][Full Text] [Related]
28. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
[TBL] [Abstract][Full Text] [Related]
29. Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.
Mittra S; Malhotra S; Naruganahalli KS; Chugh A
Eur J Pharmacol; 2007 Apr; 561(1-3):189-93. PubMed ID: 17320854
[TBL] [Abstract][Full Text] [Related]
30. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
[TBL] [Abstract][Full Text] [Related]
31. Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating.
Schreiber R; Vivian J; Hedley L; Szczepanski K; Secchi RL; Zuzow M; van Laarhoven S; Moreau JL; Martin JR; Sik A; Blokland A
Eur Neuropsychopharmacol; 2007 Mar; 17(4):277-88. PubMed ID: 16989988
[TBL] [Abstract][Full Text] [Related]
32. Co-administration of fluoxetine and WAY100635 improves short-term memory function.
Fernández-Pérez S; Pache DM; Sewell RD
Eur J Pharmacol; 2005 Oct; 522(1-3):78-83. PubMed ID: 16214127
[TBL] [Abstract][Full Text] [Related]
33. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
Dekeyne A; Brocco M; Loiseau F; Gobert A; Rivet JM; Di Cara B; Cremers TI; Flik G; Fone KC; Watson DJ; Papp M; Sharp T; Serres F; Cespuglio R; Olivier B; Chan JS; Lavielle G; Millan MJ
J Pharmacol Exp Ther; 2012 Mar; 340(3):765-80. PubMed ID: 22178753
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.
Carli M; Bonalumi P; Samanin R
Eur J Neurosci; 1998 Jan; 10(1):221-30. PubMed ID: 9753130
[TBL] [Abstract][Full Text] [Related]
35. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
[TBL] [Abstract][Full Text] [Related]
36. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
37. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
Nakayama K; Sakurai T; Katsu H
Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
[TBL] [Abstract][Full Text] [Related]
38. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
39. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
[TBL] [Abstract][Full Text] [Related]
40. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
